Is ABBV Worth Buying in 2026?

ABBVIE INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether ABBVIE INC. (ABBV) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: RSI 49 — healthy momentum range; strong 1-year return of +21.4%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.13% over 10 days). Currently 14.9% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

ABBV is trading below its 200-day MA ($217.32) — a key warning sign the longer-term trend is under pressure. An RSI of 48.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +21.4% compares to +35.1% for SPY (trailed the market by 13.7%).

$10,000 invested 1 year ago → $12,138 today
vs. S&P 500 (SPY) — same period trailed market by 13.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($217.32)
Above 50-day MA ($219.10)
RSI(14) neutral zone (30–70) — currently 48.7
Positive return (+21.4%)
!Within 10% of period high (−14.9%)
Period Range $208.38
$168.54 $244.81
RSI (14) 48.7
0 · OversoldOverbought · 100

Key Metrics

Price$208.38
Period Return+21.4%
Period High$244.81
Period Low$168.54
Drawdown−14.9%
MA-50$219.10
MA-200$217.32
RSI (14)48.7
Avg Volume (30d)7.0M
vs. SPYtrailed by 13.7%
Return Rank#549 of 996

Trade ABBV

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers